rs142236065
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_000197.2(HSD17B3):c.599C>T(p.Ala200Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000397 in 1,611,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A200A) has been classified as Likely benign.
Frequency
Consequence
NM_000197.2 missense
Scores
Clinical Significance
Conservation
Publications
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HSD17B3 | ENST00000375263.8 | c.599C>T | p.Ala200Val | missense_variant | Exon 8 of 11 | 1 | NM_000197.2 | ENSP00000364412.3 | ||
| ENSG00000285269 | ENST00000643789.1 | n.*2275C>T | non_coding_transcript_exon_variant | Exon 19 of 22 | ENSP00000494818.1 | |||||
| ENSG00000285269 | ENST00000643789.1 | n.*2275C>T | 3_prime_UTR_variant | Exon 19 of 22 | ENSP00000494818.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152256Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251332 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1459354Hom.: 0 Cov.: 30 AF XY: 0.0000454 AC XY: 33AN XY: 726194 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74388 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Testosterone 17-beta-dehydrogenase deficiency Pathogenic:3
ACMG:PM1 PM2 PP2 PP3 PP5
Variant summary: HSD17B3 c.599C>T (p.Ala200Val) results in a non-conservative amino acid change located in the NAD(P)-binding Rossmann-fold domain (IPR036291) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251332 control chromosomes. c.599C>T has been reported in the literature in individuals with clinical features of Testosterone 17-beta-dehydrogenase deficiency, including at least one compound heterozygote (e.g. Phelan_2015, Labcorp (formerly Invitae)). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal enzyme activity in vitro (e.g. Yazawa_2020). The following publications have been ascertained in the context of this evaluation (PMID: 25740850, 31614207). ClinVar contains an entry for this variant (Variation ID: 435472). Based on the evidence outlined above, the variant was classified as likely pathogenic.
not provided Pathogenic:1Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 200 of the HSD17B3 protein (p.Ala200Val). This variant is present in population databases (rs142236065, gnomAD 0.007%). This missense change has been observed in individual(s) with clinical features of 17-beta hydroxysteroid dehydrogenase 3 deficiency (PMID: 25740850; Invitae). ClinVar contains an entry for this variant (Variation ID: 435472). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HSD17B3 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Published functional studies demonstrate a deleterious effect on enzymatic function (PMID: 31614207); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36606580, Yazawa2021 [abstract], 25740850, 31614207)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at